ATE193451T1 - Verotoxin pharmazeutische zusammensetzungen und damit medizinische behandlungen - Google Patents

Verotoxin pharmazeutische zusammensetzungen und damit medizinische behandlungen

Info

Publication number
ATE193451T1
ATE193451T1 AT95908853T AT95908853T ATE193451T1 AT E193451 T1 ATE193451 T1 AT E193451T1 AT 95908853 T AT95908853 T AT 95908853T AT 95908853 T AT95908853 T AT 95908853T AT E193451 T1 ATE193451 T1 AT E193451T1
Authority
AT
Austria
Prior art keywords
verotoxin
pharmaceutical compositions
medical treatments
neoplastic
verotoxins
Prior art date
Application number
AT95908853T
Other languages
English (en)
Inventor
Clifford A Lingwood
Richard Hill
Hannah Farkas-Himsley
Original Assignee
Geva Ruth Executor For The Dec
Kroyanker Leorah Executor For
Clifford A Lingwood
Richard Hill
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geva Ruth Executor For The Dec, Kroyanker Leorah Executor For, Clifford A Lingwood, Richard Hill filed Critical Geva Ruth Executor For The Dec
Application granted granted Critical
Publication of ATE193451T1 publication Critical patent/ATE193451T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT95908853T 1994-02-22 1995-02-20 Verotoxin pharmazeutische zusammensetzungen und damit medizinische behandlungen ATE193451T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002116179A CA2116179C (en) 1994-02-22 1994-02-22 Verotoxin pharmaceutical compositions and medical treatments therewith
PCT/CA1995/000085 WO1995022349A1 (en) 1994-02-22 1995-02-20 Verotoxin pharmaceutical compositions and medical treatments therewith

Publications (1)

Publication Number Publication Date
ATE193451T1 true ATE193451T1 (de) 2000-06-15

Family

ID=4152948

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95908853T ATE193451T1 (de) 1994-02-22 1995-02-20 Verotoxin pharmazeutische zusammensetzungen und damit medizinische behandlungen

Country Status (10)

Country Link
US (1) US6228370B1 (de)
EP (1) EP0746337B1 (de)
JP (1) JPH10500103A (de)
AT (1) ATE193451T1 (de)
AU (1) AU701100B2 (de)
CA (1) CA2116179C (de)
DE (1) DE69517302T2 (de)
ES (1) ES2149347T3 (de)
NZ (1) NZ331165A (de)
WO (1) WO1995022349A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6835710B1 (en) * 1994-02-22 2004-12-28 Hsc Research & Development Limited Partnership Verotoxin pharmaceutical compositions and medical treatments therewith
AU7348998A (en) * 1997-05-16 1998-12-08 Hospital For Sick Children, The Inhibition of angiogenesis by verotoxins
AU748852B2 (en) 1998-05-20 2002-06-13 Pdl Biopharma, Inc. Humanized antibodies that recognize verotoxin II and cell line producing same
WO2000061183A2 (en) * 1999-04-09 2000-10-19 Hsc Research And Development Limited Partnership Verotoxin treatment of lymphomas
AU4691700A (en) * 1999-05-03 2000-11-17 Governors Of The University Of Alberta, The Shiga-like toxin as an enriching and purging agent
AU2003208097A1 (en) 2002-02-04 2003-09-02 Hideo Yoshida Anticancer agents using vero toxin variants

Also Published As

Publication number Publication date
WO1995022349A1 (en) 1995-08-24
JPH10500103A (ja) 1998-01-06
EP0746337A1 (de) 1996-12-11
AU701100B2 (en) 1999-01-21
EP0746337B1 (de) 2000-05-31
DE69517302T2 (de) 2001-01-18
DE69517302D1 (de) 2000-07-06
CA2116179A1 (en) 1995-08-23
AU1703195A (en) 1995-09-04
ES2149347T3 (es) 2000-11-01
US6228370B1 (en) 2001-05-08
CA2116179C (en) 2008-01-08
NZ331165A (en) 2000-01-28

Similar Documents

Publication Publication Date Title
CY1121447T1 (el) Συνθεσεις για αυξηση δραστηριοτητας τελομερασης
FI884013A (fi) Konjugat av cytokiner med immunoglobuliner.
ATE209908T1 (de) RADIKALFÄNGER (ßSPIN TRAPSß) ZUR BEHANDLUNG VON MIT OXIDATION VON LIPIDEN UND PROTEINEN VERBUNDENEN ERKRANKUNGEN
CY1105818T1 (el) Χρησεις του et743 στην θepαπευτικη αγωγη του καρκινου
PT933995E (pt) Metodo para tratamento de lesao endotelial
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
ATE197670T1 (de) Parenterales busulfan zur behandlung von malignen krankheiten
CY1108629T1 (el) Συνδυασμος ετ 743 με 5 φθοριοουρακιλο προ-φαρμακα δια την θεραπευτικη αγωγη του καρκικου
MX9708800A (es) Compuestos biciclicos aromaticos.
ES2033021T3 (es) Agente con efecto destructivo a tumores malignos, procedimiento para su obtencion y preparacion para la aplicacion en la terapia de enfermos de cancer.
ATE77230T1 (de) Melatoninhaltige mittel sowie deren verwendungen.
ATE193451T1 (de) Verotoxin pharmazeutische zusammensetzungen und damit medizinische behandlungen
GEP20043202B (en) Resorcinol Derivatives
DE69734574D1 (de) Rekombinante adenovirenvektoren zur gentherapie der menschlichen krebse
ATE128964T1 (de) Anwendung von beta-alethin in zellkultur und therapie.
ATE141510T1 (de) Arzneimittel enthaltend cd14
CA2163716A1 (en) Verotoxin pharmaceutical compositions and medical treatments therewith
ATE83657T1 (de) Pharmazeutische zusammensetzung.
RU94024337A (ru) Антиметастатическое средство
RU94021815A (ru) Способ лечения злокачественных новообразований
PT1150981E (pt) Composto nucleosidico terapeutico
KR0177821B1 (en) Pharmaceutical compositions containing 1,2-benzopyrone derivatives for the treatment of malignant tumours in humans
UA23985A (uk) Спосіб лікуваhhя запальhих захворюваhь вhутрішhіх геhіталій у дівчат та підлітків
ATE80800T1 (de) Verwendung von suramin und physiologisch vertraeglichen derivaten davon, gegebenenfalls in kombination mit anti-androgenen mitteln zur herstellung von arzneimitteln zur behandlung des humanen prostatakarzinoms.
GEP20002177B (en) Ointment “Levaskani” for Treatment of Wounds and Burns

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee